Lipofermata

CAS No. 297180-15-5

Lipofermata( —— )

Catalog No. M24217 CAS No. 297180-15-5

Lipofermata is a fatty acid transport protein (FATP) inhibitor that prevents lipid transport to melanoma cells and reduces melanoma growth and invasion.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
5MG 33 In Stock
10MG 57 In Stock
25MG 111 In Stock
50MG 182 In Stock
100MG 291 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Lipofermata
  • Note
    Research use only, not for human use.
  • Brief Description
    Lipofermata is a fatty acid transport protein (FATP) inhibitor that prevents lipid transport to melanoma cells and reduces melanoma growth and invasion.
  • Description
    Lipofermata is a fatty acid transport protein (FATP) inhibitor that prevents lipid transport to melanoma cells and reduces melanoma growth and invasion.
  • In Vitro
    Lipofermata inhibits C1-BODIPY-C12 transport into C2C12, INS-1E, Caco-2 and HepG2 cells at comparable levels yielding sigmoidal dose-response curves with IC50s in the low micromolar range (IC50=2.74-39.34 μM).
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    FATP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    297180-15-5
  • Formula Weight
    360.23
  • Molecular Formula
    C15H10BrN3OS
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (277.60 mM; Need ultrasonic)
  • SMILES
    O=C1NC2=C(C=C(Br)C=C2)C13SC(C4=CC=CC=C4)=NN3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhang M,et al. Adipocyte-Derived Lipids Mediate Melanoma Progression via FATP Proteins. Cancer Discov. 2018 Aug;8(8):1006-1025.
molnova catalog
related products
  • Sacituzumab

    Sacituzumab is a humanized IgG1 monoclonal antibody utilized in the synthesis of antibody-active small-molecule couplings (naked antibody to Sacituzumab govitecan).

  • Ensituximab

    Ensituximab (NEO-102) is a quasi-selective IgG1 monoclonal antibody against the MUC5AC variant with anti-tumour activity that inhibits colorectal and pancreatic cancer.

  • Acetylcholine iodide

    Acetylcholine iodide is a neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system.